NCT02392767View on ClinicalTrials.gov

Effect of L-Arginine and Pycnogenol on Light to Moderate Hypertension and Endothelial Function

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Endothelial DysfunctionHyperhomocysteinemia"Hypertension Grade I, Subgroup Borderline (WHO)"
Interventions
DIETARY_SUPPLEMENT

Verum

2400 mg L-arginine, 80 mg Pycnogenol, 45µg vitamine K2, 10 mg R (+) alpha lipoic acid, 8 mg vitamine B6, 500 µg vitamine B12, and 600 mg folic acid.

DIETARY_SUPPLEMENT

Placebo

corn starch

Trial Locations (1)

73728

BioTeSys, Esslingen am Neckar

All Listed Sponsors
collaborator

BioTeSys GmbH

OTHER

lead

Dr. Loges & Co. GmbH

INDUSTRY

NCT02392767 - Effect of L-Arginine and Pycnogenol on Light to Moderate Hypertension and Endothelial Function | Biotech Hunter | Biotech Hunter